Acceptability of 3D-printed breast models and their impact on the decisional conflict of breast cancer patients: A feasibility study
| Autor: | Cristina M. Checka, Joanna Lee, Lumarie Santiago, Jessica S. Colen, Robert J. Volk, Henry Mark Kuerer, Dalliah M. Black, Elsa Arribas, Catherine Liebig Akay, Abigail S. Caudle |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Oncology
Adult medicine.medical_specialty 3d printed Health Knowledge Attitudes Practice medicine.medical_treatment Breast Neoplasms Decisional conflict Disease Article Decision Support Techniques 03 medical and health sciences 0302 clinical medicine Breast cancer Internal medicine Tumor stage medicine Humans Prospective Studies Neoadjuvant therapy Mastectomy Aged business.industry Carcinoma Ductal Breast General Medicine Segmental Mastectomy Middle Aged medicine.disease Prognosis Magnetic Resonance Imaging Carcinoma Lobular Carcinoma Intraductal Noninfiltrating 030220 oncology & carcinogenesis Printing Three-Dimensional Feasibility Studies 030211 gastroenterology & hepatology Surgery Female Patient Participation business Follow-Up Studies |
| Zdroj: | J Surg Oncol |
| ISSN: | 1096-9098 |
| Popis: | PURPOSE: To evaluate the acceptability and impact of 3D printed breast models (3D-BM) on treatment-related decisional conflict (DC) of breast cancer patients. METHODS: Patients with breast cancer were accrued in a prospective IRB-approved trial. All patients underwent contrast-enhanced breast MRI (MRI). A personalized 3D-BM was derived from MRI. DC was evaluated pre and post 3D-BM review. 3D-BM acceptability was assessed post 3D-BM review. RESULTS: DC surveys before and after 3D-BM review and 3D-BM acceptability surveys were completed by 25 patients. 3D-BM were generated in 2 patients with bilateral breast cancer. The mean patient age was 48.8 years (28–72). Tumor stage was Tis (7), 1 (8), 2 (8) and 3 (4). Nodal staging was 0 (19), 1 (7), 3 (1). Tumors were unifocal (15), multifocal (8) or multicentric (4). Patients underwent mastectomy (13) and segmental mastectomy (14) with (20) or without (7) oncoplastic intervention. Neoadjuvant therapy was given to 7 patients. Patients rated the acceptability of the 3D-BM as good/excellent in understanding their condition (24/24), understanding disease size (25/25), 3D-BM detail (22/25), understanding their surgical options (24/25), encouraging to ask questions (23/25), 3D-BM size (24/25) and impartial to surgical options (17/24). There was significant reduction in overall DC post 3D-BM review, indicating patients became more assured of their treatment choice (p=0.002). Reduction post 3D-BM review was also observed in the uncertainty (p=0.012), feeling informed about options (p=.005), clarity about values (p=0.032) and effective (p=0.002) DCS subscales. CONCLUSIONS: 3D-BMs are an acceptable tool to decrease decisional conflict in breast cancer patients. CLINICAL RELEVANCE: Breast cancer patients may experience decisional conflict when considering their surgical options. 3D-BM are an acceptable, impartial tool that reduces decisional conflict in patients with breast cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text